MIRM
Mirum Pharmaceuticals Inc
NASDAQ: MIRM · HEALTHCARE · BIOTECHNOLOGY
$94.20
+0.21% today
Updated 2026-04-29
Market cap
$5.74B
P/E ratio
—
P/S ratio
11.02x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$40 – $109
Volume
0.8M
Mirum Pharmaceuticals Inc (MIRM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-4.48%
Operating margin
-3.07%
ROE
-8.65%
ROA
-1.83%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-17.35M | — | — | — |
| 2019 | $0.00 | $-52.55M | — | — | — |
| 2020 | $11.00M | $-103.27M | -5.66% | -948.15% | -938.82% |
| 2021 | $19.14M | $-83.99M | 90.06% | -906.12% | -438.85% |
| 2022 | $77.06M | $-135.66M | 83.94% | -170.28% | -176.05% |
| 2023 | $186.37M | $-163.41M | 74.76% | -58.57% | -87.68% |
| 2024 | $336.89M | $-87.94M | 75.77% | -26.00% | -26.10% |
| 2025 | $521.31M | $-23.36M | 80.71% | -4.25% | -4.48% |